86 related articles for article (PubMed ID: 3040308)
21. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
[TBL] [Abstract][Full Text] [Related]
22. Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.
González-Amaro R; Salazar-González JF; Baranda L; Abud-Mendoza C; Moncada B; García R; Alcocer-Varela J
Clin Exp Immunol; 1988 Mar; 71(3):399-404. PubMed ID: 3133142
[TBL] [Abstract][Full Text] [Related]
23. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
[TBL] [Abstract][Full Text] [Related]
25. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
26. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
Reitan LJ; Closs O
Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
[TBL] [Abstract][Full Text] [Related]
27. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
29. Effect of preincubation on the proliferative response to antigen by cells from leprosy patients and healthy controls.
Mullins RJ; Basten A
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):777-87. PubMed ID: 2681460
[TBL] [Abstract][Full Text] [Related]
30. Immunology of leprosy: cellular anergy to Mycobacterium leprae.
Rojas-Espinosa O; Estrada-Parra S
Arch Invest Med (Mex); 1989; 20(4):335-41. PubMed ID: 2518718
[No Abstract] [Full Text] [Related]
31. Comparative study of anti-PGL-1, anti-35 kDa and anti-lipoarabinomannan assays for serodiagnosis of leprosy.
Jayapal V; Selvibai G; Mahalakshmi K; Pushkala ; Regunath K; Subramanian S
Indian J Lepr; 2001; 73(3):229-37. PubMed ID: 11840595
[TBL] [Abstract][Full Text] [Related]
32. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
33. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117
[TBL] [Abstract][Full Text] [Related]
34. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease.
Sampaio EP; Moreira AL; Kaplan G; Alvim MF; Duppre NC; Miranda CF; Sarno EN
J Infect Dis; 1991 Nov; 164(5):990-3. PubMed ID: 1940481
[TBL] [Abstract][Full Text] [Related]
36. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
37. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
38. Cellular, humoral, and gamma interferon responses to Mycobacterium leprae and BCG antigens in healthy individuals exposed to leprosy.
Converse PJ; Ottenhoff TH; Gebre N; Ehrenberg JP; Kiessling R
Scand J Immunol; 1988 May; 27(5):515-25. PubMed ID: 3131867
[TBL] [Abstract][Full Text] [Related]
39. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
40. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
